Franck Grall

Franck Grall has an extensive work experience spanning over several companies and roles. Franck started their career as a Resident at Assistance publique- hopitaux de paris in 1997, followed by a role as a Pharmacist Officer at the Blood Bank of the French Armies in 1997-1998. Franck then worked as an Intern at Genopoietic for a brief period in 1998.

In 1998, Grall joined BIDMC / Harvard Medical School as an Instructor in Medicine / Research Associate, where they remained until 2007. During this time, they gained expertise in medicine and research.

Grall then transitioned to the Toxikon Corporation in 2007, where they served as the Department Head of Cell Services until 2017. In this role, they contributed to the company's cell services operations.

Following their tenure at Toxikon Corporation, Grall joined Cambridge Biomedical Inc. in 2017 as a Senior Research Scientist. Franck later became the Director of Scientific Services in 2018, a position they held until 2022.

Since 2019, Grall has been working at BioAgilytix. Franck started as the Director of Scientific Services and has recently become the Vice President & General Manager of Boston Operations.

Overall, Grall has demonstrated a strong background in scientific services and management, with notable experience in the pharmaceutical and medical research industry.

Franck Grall completed their education at Paris-Sud University (Paris XI), where they obtained a Pharm D degree in Pharmacy in 1998. Franck later pursued a Master's degree in Health Law from the same university, which they completed in 1998 as well. Subsequently, Franck Grall furthered their education and earned a PhD in Molecular Biology from Paris-Sud University (Paris XI) between 2000 and 2002.